Institute of Minimally Invasive Surgical Sciences and Research, Saifee Hospital, 15/17 Maharshi Karve Marg, Opera House, Mumbai, 400004, India.
, Mumbai, India.
Obes Surg. 2019 Nov;29(11):3478-3483. doi: 10.1007/s11695-019-04011-2.
Obesity is associated with metabolic syndrome, nonalcoholic steatohepatitis, and kidney disease. BMI may not be the ideal measure of obesity when used to assess its effect on kidney disease as it does not discriminate for age, sex, ethnicity, muscle, bone, or fat mass.
To assess the prevalence microalbuminuria and identify independent risk factors for development of kidney disease in the obese Indian population.
Age, weight, BMI, total body fat percentage, waist-to-hip ratio, hypertension, urinary albumin-to-creatinine ratio (UACR), and HbA1c were collected from 568 obese patients, presenting for bariatric surgery. Multivariate binary logistic regression was used to identify independent risk factors for kidney disease.
A total of 114 out of 568 (20.07%) obese patients had microalbuminuria (UACR range 30-283 μg/mg). HbA1C levels ≥ 6 (p = 0.01) and hypertension (p = 0.03) were the strongest independent variables for microalbuminuria. 14.67% with a BMI < 35 kg/m, 21.30% with a BMI 35-50 kg/m, and 19.44% with a BMI > 50 kg/m had microalbuminuria. Increasing BMI however was not statistically significant (p = 0.75). Total body fat percentage (p = 0.51), waist-to-hip ratio (p = 0.96), age (p = 0.30), sex (p = 0.38), and BMI (p = 0.75) were found to be statistically insignificant.
Kidney disease afflicts 1/5th of the obese Indian patients studied. Diabetes and hypertension remained as the most significant risk factors, while age, weight, increasing BMI, waist-to-hip ratio, or increasing body fat were found to be statistically insignificant for development and progression of kidney disease.
肥胖与代谢综合征、非酒精性脂肪性肝炎和肾脏疾病有关。当 BMI 用于评估其对肾脏疾病的影响时,它不能区分年龄、性别、种族、肌肉、骨骼或脂肪量,因此可能不是评估肥胖的理想指标。
评估肥胖印度人群中微量白蛋白尿的患病率,并确定导致肾脏疾病的独立危险因素。
从 568 名接受减肥手术的肥胖患者中收集年龄、体重、BMI、体脂肪百分比、腰臀比、高血压、尿白蛋白与肌酐比值(UACR)和 HbA1c。使用多元二项逻辑回归来确定肾脏疾病的独立危险因素。
在 568 名肥胖患者中,共有 114 名(20.07%)患有微量白蛋白尿(UACR 范围为 30-283μg/mg)。HbA1C 水平≥6(p=0.01)和高血压(p=0.03)是微量白蛋白尿的最强独立变量。BMI<35kg/m2 的患者中,有 14.67%患有微量白蛋白尿;BMI 在 35-50kg/m2 的患者中,有 21.30%患有微量白蛋白尿;BMI>50kg/m2 的患者中,有 19.44%患有微量白蛋白尿。但 BMI 的增加并不具有统计学意义(p=0.75)。体脂肪百分比(p=0.51)、腰臀比(p=0.96)、年龄(p=0.30)、性别(p=0.38)和 BMI(p=0.75)均无统计学意义。
所研究的肥胖印度患者中有 1/5患有肾脏疾病。糖尿病和高血压仍然是最重要的危险因素,而年龄、体重、BMI 增加、腰臀比或体脂肪增加与肾脏疾病的发生和进展无统计学意义。